Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Pre-Close Trading Update

18 May 2016 07:00

RNS Number : 5314Y
Ideagen PLC
18 May 2016
 

18 May 2016

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Pre-Close Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2016 ahead of the announcement of its full year results.

 

The Board is pleased to report that trading for the year was robust and results to 30 April 2016 are expected to be in line with market expectations. The Group delivered strong organic revenue growth of 10 per cent., and a full year contribution from Gael which was acquired in January 2015.

 

The Group expects to report revenue of approximately £21.9 million (FY2015: £14.4 million), an increase of 52 per cent. resulting in adjusted EBITDA* of approximately £6.3 million (FY2015: £4.0 million), an increase of 57 per cent. This represents the Group's seventh consecutive year of revenue and EBITDA* growth. In addition, the Group expects to show a significant increase in adjusted EPS** which continues to be an important financial metric for the Group.

 

Cash generation remained strong, particularly in the second half of the year, and net cash at 30 April 2016 was £6.3 million (31 October 2015: £5.4 million), after paying £1.7 million of deferred consideration, principally for the Gael acquisition, and £0.3 million in dividends. The Group continues to maintain a debt-free balance sheet.

 

The strong trading results have been driven predominately by healthy demand across the Group's Governance, Risk and Compliance ("GRC") markets, including the manufacturing, life sciences, aviation and rail verticals. The Board is also encouraged by the success of the Group's newly launched SaaS platform, Enlighten, which is allowing the Group to win larger contracts and grow high visibility, subscription-based revenue. As a result, the Board remains confident in the long term growth prospects for the Group.

 

David Hornsby, Chief Executive, commented: "The Group has once again delivered another year of high quality earnings growth, demonstrating the strength of our business model, the quality of our products and the talent of our employees. The Group has significant contracted work in progress, a growing recurring revenue base and a healthy pipeline of new business, which leaves me optimistic about the continued growth opportunities for the Group."

 

*Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and exceptional items.

**Adjusted diluted earnings per share

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

Alma PR

 

Hilary Buchanan

+44 (0)7515 805218

Josh Royston

+44 (0)7780 901979

 

 

About Ideagen Group plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.

 

The Group has a customer base of over 2,200 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDDLFFQEFZBBD
Date   Source Headline
10th Aug 201711:45 amRNSDirector Dealing
28th Jul 20174:19 pmRNSDirector Dealing
18th Jul 20177:00 amRNSFinal Results
12th Jun 20178:45 amRNSHolding(s) in Company
18th May 20173:19 pmRNSExercise of Options and Total Voting Rights
17th May 20177:00 amRNSPre-Close Trading Update
11th May 20172:21 pmRNSHolding(s) in Company
31st Mar 20171:10 pmRNSDirector/PDMR Shareholding
30th Mar 201711:48 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSNew Aviation SaaS contracts worth £1.8m
28th Mar 20179:16 amRNSHolding(s) in Company
27th Mar 20176:05 pmRNSHolding(s) in Company
23rd Mar 201710:49 amRNSDirectors' Dealing & Total Voting Rights
23rd Mar 20177:00 amRNSAcquisition and Placing to raise £10m
1st Mar 201711:47 amRNSExercise of Options and Total Voting Rights
1st Mar 20177:00 amRNSHolding(s) in Company
24th Feb 20172:28 pmRNSExercise of Options and Total Voting Rights
24th Feb 201712:20 pmRNSHolding(s) in Company
21st Feb 20177:00 amRNSExercise of Options and Total Voting Rights
1st Feb 201711:44 amRNSHolding(s) in Company
26th Jan 20178:29 amRNSDividend Timetable
24th Jan 20177:01 amRNSDirectorate Changes
24th Jan 20177:00 amRNSInterim Results
9th Dec 20167:00 amRNSAcquisition of IPI Solutions Ltd
7th Dec 20162:14 pmRNSHolding(s) in Company
28th Nov 20164:55 pmRNSHolding(s) in Company
24th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 201611:37 amRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Update
2nd Nov 20167:00 amRNSExercise of Options and Total Voting Rights
28th Oct 20161:26 pmRNSResult of AGM
13th Oct 20167:00 amRNSNew Contract Wins worth £1.2m
11th Oct 20167:00 amRNSExercise of Options and Total Voting Rights
6th Oct 20167:00 amRNSNotice of AGM
6th Sep 20167:00 amRNSAcquisition of Logen Ltd.
1st Sep 20167:00 amRNSExercise of Options and Total Voting Rights
12th Aug 20167:00 amRNSExercise of Options and Total Voting Rights
8th Aug 20167:00 amRNSAcquisition of Covalent Software Ltd
29th Jul 20167:00 amRNSExercise of Options and Total Voting Rights
19th Jul 20163:28 pmRNSDividend Timetable
19th Jul 20167:00 amRNSFinal Results
12th Jul 20167:00 amRNSNotice of Results
5th Jul 20167:00 amRNSHolding(s) in Company
29th Jun 20161:56 pmRNSHolding(s) in Company
18th May 20167:00 amRNSPre-Close Trading Update
5th May 20167:00 amRNSExercise of Options and Total Voting Rights
29th Apr 20167:00 amRNSNew contract wins in life science sector
29th Mar 20167:00 amRNSExercise of Options and Total Voting Rights
18th Mar 20167:00 amRNSRe £4.9m Contract and Trading Update
29th Jan 20168:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.